LGT Financial Advisors LLC reduced its stake in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 14.3% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 605 shares of the company’s stock after selling 101 shares during the quarter. LGT Financial Advisors LLC’s holdings in Procter & Gamble were worth $105,000 as of its most recent SEC filing.
A number of other hedge funds also recently modified their holdings of PG. Itau Unibanco Holding S.A. bought a new position in Procter & Gamble in the second quarter valued at about $28,000. Fairway Wealth LLC bought a new stake in shares of Procter & Gamble during the 2nd quarter valued at approximately $29,000. Ruedi Wealth Management Inc. boosted its position in Procter & Gamble by 64.7% in the first quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock valued at $32,000 after buying an additional 77 shares in the last quarter. POM Investment Strategies LLC acquired a new position in shares of Procter & Gamble during the second quarter worth $34,000. Finally, Quest Partners LLC bought a new position in shares of Procter & Gamble in the 2nd quarter valued at $36,000. Institutional investors own 65.77% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of equities analysts have issued reports on PG shares. Morgan Stanley upped their target price on Procter & Gamble from $174.00 to $191.00 and gave the stock an “overweight” rating in a report on Monday, October 21st. Citigroup raised their price objective on shares of Procter & Gamble from $177.00 to $190.00 and gave the company a “buy” rating in a report on Wednesday, July 10th. JPMorgan Chase & Co. boosted their target price on shares of Procter & Gamble from $179.00 to $186.00 and gave the stock an “overweight” rating in a report on Thursday, September 19th. Wolfe Research raised shares of Procter & Gamble to a “strong-buy” rating in a research note on Friday, August 23rd. Finally, DZ Bank raised shares of Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 price objective on the stock in a research note on Thursday, August 29th. Nine equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $177.00.
Insider Transactions at Procter & Gamble
In other Procter & Gamble news, insider Balaji Purushothaman sold 12,800 shares of Procter & Gamble stock in a transaction dated Thursday, October 24th. The stock was sold at an average price of $168.99, for a total transaction of $2,163,072.00. Following the completion of the transaction, the insider now owns 11,566 shares in the company, valued at approximately $1,954,538.34. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, insider Balaji Purushothaman sold 12,800 shares of the stock in a transaction dated Thursday, October 24th. The shares were sold at an average price of $168.99, for a total value of $2,163,072.00. Following the completion of the sale, the insider now owns 11,566 shares in the company, valued at $1,954,538.34. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Jon R. Moeller sold 72,174 shares of the company’s stock in a transaction dated Friday, August 9th. The stock was sold at an average price of $171.01, for a total transaction of $12,342,475.74. Following the completion of the sale, the chief executive officer now directly owns 263,158 shares of the company’s stock, valued at $45,002,649.58. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 385,771 shares of company stock valued at $65,610,975 over the last three months. Corporate insiders own 0.18% of the company’s stock.
Procter & Gamble Trading Down 2.9 %
PG opened at $160.99 on Thursday. The company has a fifty day moving average price of $171.29 and a two-hundred day moving average price of $168.13. The Procter & Gamble Company has a 1-year low of $142.50 and a 1-year high of $177.94. The company has a market cap of $379.14 billion, a P/E ratio of 27.76, a price-to-earnings-growth ratio of 3.57 and a beta of 0.42. The company has a current ratio of 0.75, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50.
Procter & Gamble (NYSE:PG – Get Free Report) last issued its earnings results on Friday, October 18th. The company reported $1.93 EPS for the quarter, beating analysts’ consensus estimates of $1.90 by $0.03. The business had revenue of $21.74 billion during the quarter, compared to analyst estimates of $21.99 billion. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The firm’s revenue was down .6% compared to the same quarter last year. During the same period in the previous year, the company posted $1.83 EPS. Analysts predict that The Procter & Gamble Company will post 6.94 EPS for the current fiscal year.
Procter & Gamble Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be paid a dividend of $1.0065 per share. The ex-dividend date of this dividend is Friday, October 18th. This represents a $4.03 dividend on an annualized basis and a yield of 2.50%. Procter & Gamble’s dividend payout ratio (DPR) is presently 69.48%.
About Procter & Gamble
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
See Also
- Five stocks we like better than Procter & Gamble
- Why Invest in 5G? How to Invest in 5G Stocks
- What a Trump Win Looks Like for the Market Now and Into 2025
- The 3 Best Blue-Chip Stocks to Buy Now
- Russell 2000 Surge Post-Election: How to Play the Small-Cap Pop
- Investing in Construction Stocks
- Macro Headwinds Send Microchip Technology Stock to the Buy Zone
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.